Armata Pharmaceuticals Inc
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 16 | Q4 16 | Q1 17 | Q2 17 | Q3 17 | Q4 17 | Q1 18 | Q2 18 | Q3 18 | Q4 18 | Q1 19 | Q2 19 | Q3 19 | Q4 19 | Q1 20 | Q2 20 | Q3 20 | Q4 20 | Q1 21 | Q2 21 | Q3 21 | Q4 21 | Q1 22 | Q2 22 | Q3 22 | Q4 22 | Q1 23 | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | – | – | – | – | – | – | – | – | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | – | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| – | – | – | – | 244.7% | 480.0% | 485.0% | – | – | – | – | – | – | – | – | 8,541.9% | 1,411.8% | 988.1% | 408.1% | 447.3% | 449.7% | 486.8% | 649.5% | 479.0% | 627.8% | 910.5% | 1,206.5% | 20.4% | 18.0% | 19.2% | 32.8% | – | 10.5% | 30.8% | 76.8% | 16.9% | 31.9% | 38.5% | 57.9% | 23.5% | 33.1% | |
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | – | – | – | – | – | – | – | – | – | -8,441.9% | -1,311.8% | -888.1% | -308.1% | -347.3% | -349.7% | -386.8% | -549.5% | -379.0% | -527.8% | -810.5% | -1,106.5% | 79.6% | 82.0% | 80.8% | 67.2% | – | 89.5% | 69.2% | 23.2% | 83.1% | 68.1% | 61.5% | 42.1% | 76.5% | 66.9% | |
| 5,706.9% | 3,645.5% | 5,137.9% | 4,035.7% | 2,181.6% | 5,450.0% | 7,320.0% | – | – | – | – | – | – | – | – | 8,541.9% | 1,411.8% | 988.1% | 408.1% | 447.3% | 449.7% | 486.8% | 649.5% | 479.0% | 627.8% | 910.5% | 1,206.5% | 842.8% | 651.3% | 518.8% | 829.8% | – | 319.0% | 684.2% | 1,105.7% | 294.8% | 502.5% | 559.4% | 774.5% | 302.2% | 461.7% | |
| 6,141.4% | 6,986.4% | 6,544.8% | 9,942.9% | 4,244.7% | 6,475.0% | 7,955.0% | – | – | – | – | – | – | – | – | 6,364.5% | 640.6% | 392.3% | 201.8% | 183.1% | 141.3% | 224.8% | 160.4% | 110.6% | 116.7% | 172.2% | 318.8% | 239.8% | 292.5% | 208.0% | 329.0% | – | 109.1% | 269.1% | 662.5% | 120.7% | 268.4% | 315.8% | 438.9% | 208.6% | 274.9% | |
| 11,848.3% | 10,631.8% | 11,682.8% | 13,978.6% | 6,426.3% | 11,445.0% | 15,275.0% | – | – | – | – | – | – | – | – | 6,364.5% | 640.6% | 392.3% | 201.8% | 183.1% | 141.3% | 224.8% | 160.4% | 110.6% | 116.7% | 172.2% | 318.8% | 1,062.1% | 925.7% | 707.7% | 1,126.0% | – | 417.3% | 922.6% | 1,691.4% | 398.7% | 670.9% | 1,274.0% | 1,155.5% | 487.3% | 774.8% | |
| -11,748.3% | -10,531.8% | -11,582.8% | -34,592.9% | -1,963.2% | -11,825.0% | -15,275.0% | – | – | – | – | – | – | – | – | -14,806.5% | -1,952.4% | -1,280.4% | -509.8% | -530.5% | -491.0% | -611.5% | -710.0% | -489.6% | -644.5% | -982.7% | -1,425.4% | -982.6% | -843.8% | -626.9% | -1,058.8% | – | -328.2% | -853.4% | -1,668.2% | -315.5% | -670.9% | -1,274.0% | -1,113.4% | -410.8% | -734.2% | |
| – | – | – | – | – | – | 440.0% | – | – | – | – | – | – | – | – | 458.1% | 52.1% | 35.1% | 5.8% | 0.2% | 0.2% | 6.5% | 0.1% | 0.3% | 0.7% | 1.3% | 395.0% | 0.0% | 96.0% | 94.9% | 188.4% | – | 98.3% | 265.6% | 733.6% | 175.6% | 375.0% | 445.5% | 704.6% | 264.3% | 385.6% | |
| -8,189.7% | -45,709.1% | -11,193.1% | -27,725.0% | -2,050.0% | -11,760.0% | -15,670.0% | – | – | – | – | – | – | – | – | -15,193.5% | -2,003.1% | -1,314.3% | -515.5% | -530.3% | -433.2% | -611.4% | -709.9% | -489.4% | -643.8% | -981.4% | -1,820.4% | -361.9% | -2,543.8% | -1,298.9% | -2,590.2% | – | -184.4% | 210.5% | -1,330.1% | -751.3% | -2,301.6% | -11,456.0% | -14,619.3% | 2,953.8% | -3,467.0% | |
| -3,558.6% | -2,527.3% | -389.7% | -4,650.0% | 86.8% | -65.0% | 395.0% | – | – | – | – | – | – | – | – | 71.0% | 1.4% | 1.2% | – | 0.2% | 0.2% | 0.1% | -0.1% | -0.3% | -0.7% | -1.3% | 395.0% | -639.2% | -1,196.5% | 1,163.4% | 28.3% | – | – | -22.2% | – | – | – | – | – | – | – | |
| -8,189.7% | -43,181.8% | -11,193.1% | -23,075.0% | -2,050.0% | -11,760.0% | -15,670.0% | – | – | – | – | – | – | – | – | -15,193.5% | -2,003.1% | -1,314.3% | -515.5% | -530.3% | -433.2% | -611.4% | -709.9% | -489.4% | -643.8% | -981.4% | -1,820.4% | -361.9% | -2,543.8% | -1,298.9% | -2,590.2% | – | -184.4% | 210.5% | -1,330.1% | -751.3% | -2,301.6% | -11,456.0% | -14,619.3% | 2,953.8% | -3,467.0% | |
| -11,420.7% | -10,072.7% | -11,262.1% | -13,550.0% | -1,718.4% | -11,345.0% | -14,790.0% | – | – | – | – | – | – | – | – | -13,903.2% | -1,860.4% | -1,226.0% | -483.3% | -504.9% | -407.9% | -583.4% | -691.6% | -479.0% | -626.9% | -958.0% | -1,791.5% | -341.5% | -2,429.7% | -1,184.8% | -2,368.9% | – | -75.5% | 506.9% | -519.8% | -558.8% | -1,894.7% | -10,972.0% | -13,856.8% | 3,241.7% | -3,048.3% |
LTM = last twelve months (sum of the four most recent quarters).
Showing the most recent 40 periods — older statements are on file for this stock.
Data as of: October 8, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.